Metformin and Everolimus: A Promising Combination for Neuroendocrine Tumors Treatment
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Metformin and Everolimus: A Promising Combination for Neuroendocrine Tumors Treatment
Authors
Keywords
-
Journal
Cancers
Volume 12, Issue 8, Pages 2143
Publisher
MDPI AG
Online
2020-08-03
DOI
10.3390/cancers12082143
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A novel insight into the anticancer mechanism of metformin in pancreatic neuroendocrine tumor cells
- (2020) E. Vitali et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- Metformin Counteracts HCC Progression and Metastasis Enhancing KLF6/p21 Expression and Downregulating the IGF Axis
- (2019) Fernanda Vacante et al. International Journal of Endocrinology
- Effects of novel somatostatin-dopamine chimeric drugs in 2D and 3D cell culture models of neuroendocrine tumors
- (2019) Aura D Herrera-Martínez et al. ENDOCRINE-RELATED CANCER
- The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance
- (2018) Elke Tatjana Aristizabal Prada et al. ENDOCRINE-RELATED CANCER
- Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues
- (2018) Sara Pusceddu et al. GASTROENTEROLOGY
- Role of Phosphodiesterases on the Function of Aryl Hydrocarbon Receptor-Interacting Protein (AIP) in the Pituitary Gland and on the Evaluation of AIP Gene Variants
- (2017) Laura Hernández-Ramírez et al. HORMONE AND METABOLIC RESEARCH
- FLNA is implicated in pulmonary neuroendocrine tumors aggressiveness and progression
- (2017) Eleonora Vitali et al. Oncotarget
- Neuroendocrine Tumors
- (2017) Journal of the National Comprehensive Cancer Network
- Long-term acquired everolimus resistance in pancreatic neuroendocrine tumours can be overcome with novel PI3K-AKT-mTOR inhibitors
- (2016) Timon Vandamme et al. BRITISH JOURNAL OF CANCER
- Filamin-A is required to mediate SST2 effects in pancreatic neuroendocrine tumours
- (2016) Eleonora Vitali et al. ENDOCRINE-RELATED CANCER
- Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes
- (2016) Sara Pusceddu et al. Future Oncology
- Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study
- (2016) James C Yao et al. LANCET
- ENETS Consensus Guidelines Update for the Management of Distant Metastatic Disease of Intestinal, Pancreatic, Bronchial Neuroendocrine Neoplasms (NEN) and NEN of Unknown Primary Site
- (2016) M. Pavel et al. NEUROENDOCRINOLOGY
- Akt/PKB: one kinase, many modifications
- (2015) Guillermo Risso et al. BIOCHEMICAL JOURNAL
- Molecular Mechanisms of Mitochondrial Autophagy/Mitophagy in the Heart
- (2015) T. Saito et al. CIRCULATION RESEARCH
- Combined Use of Metformin and Everolimus Is Synergistic in the Treatment of Breast Cancer Cells
- (2015) Yunshan Wang et al. ONCOLOGY RESEARCH
- New mechanisms of metformin action: Focusing on mitochondria and the gut
- (2015) Kyu Yeon Hur et al. Journal of Diabetes Investigation
- Metformin repositioning as antitumoral agent: selective antiproliferative effects in human glioblastoma stem cells, via inhibition of CLIC1-mediated ion current
- (2015) Marta Gritti et al. Oncotarget
- Exploring the rising incidence of neuroendocrine tumors: A population-based analysis of epidemiology, metastatic presentation, and outcomes
- (2014) Julie Hallet et al. CANCER
- Anticancer effects of metformin on neuroendocrine tumor cells in vitro
- (2014) George Vlotides et al. Hormones-International Journal of Endocrinology and Metabolism
- Mechanism of Metformin-dependent Inhibition of Mammalian Target of Rapamycin (mTOR) and Ras Activity in Pancreatic Cancer
- (2014) Vijayalekshmi Nair et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- PI3K and cancer: lessons, challenges and opportunities
- (2014) David A. Fruman et al. NATURE REVIEWS DRUG DISCOVERY
- Metformin—mode of action and clinical implications for diabetes and cancer
- (2014) Ida Pernicova et al. Nature Reviews Endocrinology
- Everolimus in Advanced Pancreatic Neuroendocrine Tumors: The Clinical Experience
- (2013) J. C. Yao et al. CANCER RESEARCH
- Dual Inhibition of PI3K and mTOR Signaling Pathways Decreases Human Pancreatic Neuroendocrine Tumor Metastatic Progression
- (2013) Clarisse Djukom et al. PANCREAS
- Neuroendocrine bronchial and thymic tumors: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2012) K. Oberg et al. ANNALS OF ONCOLOGY
- Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms
- (2012) Kathrin Zitzmann et al. ENDOCRINE-RELATED CANCER
- The Antidiabetic Drug Metformin Inhibits Gastric Cancer Cell Proliferation In Vitro and In Vivo
- (2012) K. Kato et al. MOLECULAR CANCER THERAPEUTICS
- Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
- (2012) Hiroshi Noto et al. PLoS One
- Human Neuroendocrine Tumor Cell Lines as a Three-Dimensional Model for the Study of Human Neuroendocrine Tumor Therapy
- (2012) Chung Wong et al. Jove-Journal of Visualized Experiments
- Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells
- (2011) B. Bao et al. Cancer Prevention Research
- In vitro and in vivo anti-melanoma action of metformin
- (2011) Kristina Janjetovic et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- mTOR Activation in Well Differentiated Pancreatic Neuroendocrine Tumors: A Retrospective Study on 34 Cases
- (2011) Chen-Fei Zhou et al. HEPATO-GASTROENTEROLOGY
- Metformin Induces Both Caspase-Dependent and Poly(ADP-ribose) Polymerase-Dependent Cell Death in Breast Cancer Cells
- (2011) Y. Zhuang et al. MOLECULAR CANCER RESEARCH
- Everolimus for Advanced Pancreatic Neuroendocrine Tumors
- (2011) James C. Yao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pancreatic Endocrine Tumors: Expression Profiling Evidences a Role for AKT-mTOR Pathway
- (2009) Edoardo Missiaglia et al. JOURNAL OF CLINICAL ONCOLOGY
- Spheroid-based drug screen: considerations and practical approach
- (2009) Juergen Friedrich et al. Nature Protocols
- Pancreatic neuroendocrine tumors (PNETs): incidence, prognosis and recent trend toward improved survival
- (2008) T. R. Halfdanarson et al. ANNALS OF ONCOLOGY
- Metformin induces apoptosis of pancreatic cancer cells
- (2008) Luo-Wei Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started